H2AX and central nervous system cancer: Axitinib induces DNA damage response (DDR) characterized by γ-H2AX phosphorylation and Chk1 kinase activation leading to G2/M cell cycle arrest and mitotic catastrophe in glioma cell lines.Combined exposure to axitinib and bortezomib was more effective in inhibiting cell viability of all glioma cell lines.